{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:22:20Z","timestamp":1788225740601,"version":"build-2803163510"},"reference-count":52,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0409"],"award-info":[{"award-number":["W81XWH-19-1-0409"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Powassan virus (POWV) is an emerging tick-borne virus and cause of lethal encephalitis in humans. The lack of treatment or prevention strategies for POWV disease underscores the need for an effective POWV vaccine. Here, we took two independent approaches to develop vaccine candidates. First, we recoded the POWV genome to increase the dinucleotide frequencies of CpG and UpA to potentially attenuate the virus by raising its susceptibility to host innate immune factors, such as the zinc-finger antiviral protein (ZAP). Secondly, we took advantage of the live-attenuated yellow fever virus vaccine 17D strain (YFV-17D) as a vector to express the structural genes pre-membrane (prM) and envelope (E) of POWV. The chimeric YFV-17D-POWV vaccine candidate was further attenuated for in vivo application by removing an N-linked glycosylation site within the nonstructural protein (NS)1 of YFV-17D. This live-attenuated chimeric vaccine candidate significantly protected mice from POWV disease, conferring a 70% survival rate after lethal challenge when administered in a homologous two-dose regimen. Importantly, when given in a heterologous prime-boost vaccination scheme, in which vaccination with the initial chimeric virus was followed by a protein boost with the envelope protein domain III (EDIII), 100% of the mice were protected without showing any signs of morbidity. Combinations of this live-attenuated chimeric YFV-17D-POWV vaccine candidate with an EDIII protein boost warrant further studies for the development of an effective vaccine strategy for the prevention of POWV disease.<\/jats:p>","DOI":"10.3390\/vaccines11030612","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T05:01:12Z","timestamp":1678251672000},"page":"612","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Characterization of Live-Attenuated Powassan Virus Vaccine Candidates Identifies an Efficacious Prime-Boost Strategy for Mitigating Powassan Virus Disease in a Murine Model"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5673-4247","authenticated-orcid":false,"given":"Andrew M.","family":"Cheung","sequence":"first","affiliation":[{"name":"Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Z.","family":"Yip","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1114-1426","authenticated-orcid":false,"given":"Alison W.","family":"Ashbrook","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2906-5513","authenticated-orcid":false,"given":"Niluka","family":"Goonawardane","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrine","family":"Quirk","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Rice","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5177-2068","authenticated-orcid":false,"given":"Margaret R.","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0554-0244","authenticated-orcid":false,"given":"Hans-Heinrich","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/vbz.2017.2110","article-title":"Powassan Virus: An Emerging Arbovirus of Public Health Concern in North America","volume":"17","author":"Hermance","year":"2017","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.15585\/mmwr.mm6717e1","article-title":"Vital Signs: Trends in Reported Vectorborne Disease Cases\u2014United States and Territories, 2004-2016","volume":"67","author":"Rosenberg","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/jme\/tjab064","article-title":"The Rise of Ticks and Tickborne Diseases in the United States-Introduction","volume":"58","author":"Beard","year":"2021","journal-title":"J. Med. Entomol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4269\/ajtmh.2012.12-0294","article-title":"Prevalence and genetic characterization of Powassan virus strains infecting Ixodes scapularis in Connecticut","volume":"87","author":"Anderson","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s42003-021-02828-1","article-title":"Incrimination of shrews as a reservoir for Powassan virus","volume":"4","author":"Goethert","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.virol.2010.03.035","article-title":"Homogeneity of Powassan virus populations in naturally infected Ixodes scapularis","volume":"402","author":"Brackney","year":"2010","journal-title":"Virology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1099\/vir.0.024232-0","article-title":"Molecular epidemiology of Powassan virus in North America","volume":"91","author":"Pesko","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1016\/j.celrep.2018.11.082","article-title":"An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections","volume":"25","author":"VanBlargan","year":"2018","journal-title":"Cell Rep."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Choi, H., Kudchodkar, S.B., Ho, M., Reuschel, E.L., Reynolds, E., Xu, Z., Bordoloi, D., Ugen, K.E., Tebas, P., and Kim, J. (2020). A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008788"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"110388","DOI":"10.1016\/j.celrep.2022.110388","article-title":"Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccination","volume":"38","author":"Stone","year":"2022","journal-title":"Cell Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Malonis, R.J., Georgiev, G.I., Haslwanter, D., VanBlargan, L.A., Fallon, G., Vergnolle, O., Cahill, S.M., Harris, R., Cowburn, D., and Chandran, K. (2022). A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010573"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"24303","DOI":"10.1073\/pnas.1913232116","article-title":"Structure of the zinc-finger antiviral protein in complex with RNA reveals a mechanism for selective targeting of CG-rich viral sequences","volume":"116","author":"Meagher","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1073\/pnas.0607063104","article-title":"The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA","volume":"104","author":"Guo","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1038\/emboj.2012.271","article-title":"Translational repression precedes and is required for ZAP-mediated mRNA decay","volume":"31","author":"Zhu","year":"2012","journal-title":"EMBO J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41564-022-01223-8","article-title":"Rational attenuation of RNA viruses with zinc finger antiviral protein","volume":"7","author":"Mastrocola","year":"2022","journal-title":"Nat. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e29112","DOI":"10.7554\/eLife.29112","article-title":"CpG and UpA dinucleotides in both coding and non-coding regions of echovirus 7 inhibit replication initiation post-entry","volume":"6","author":"Fros","year":"2017","journal-title":"eLife"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wieten, R.W., Jonker, E.F., van Leeuwen, E.M., Remmerswaal, E.B., Ten Berge, I.J., de Visser, A.W., van Genderen, P.J., Goorhuis, A., Visser, L.G., and Grobusch, M.P. (2016). A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149871"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.84.7.2019","article-title":"Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it","volume":"84","author":"Hahn","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1016\/j.vaccine.2017.03.032","article-title":"Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease","volume":"35","author":"Barrett","year":"2017","journal-title":"Vaccine"},{"key":"ref_21","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull. World Health Organ."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12794","DOI":"10.1128\/JVI.01160-13","article-title":"Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins","volume":"87","author":"James","year":"2013","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.1402605","article-title":"CD8+ T cells complement antibodies in protecting against yellow fever virus","volume":"194","author":"Bassi","year":"2015","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhang, X., Jia, R., Shen, H., Wang, M., Yin, Z., and Cheng, A. (2017). Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections. Viruses, 9.","DOI":"10.3390\/v9110338"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1128\/JVI.76.24.13097-13100.2002","article-title":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein","volume":"76","author":"Beasley","year":"2002","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri3916","article-title":"New insights into the immunopathology and control of dengue virus infection","volume":"15","author":"Screaton","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1586\/erv.10.139","article-title":"IMOJEV((R)): A Yellow fever virus-based novel Japanese encephalitis vaccine","volume":"9","author":"Appaiahgari","year":"2010","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"25151355211015839","DOI":"10.1177\/25151355211015839","article-title":"Dengvaxia: The world\u2019s first vaccine for prevention of secondary dengue","volume":"9","author":"Tully","year":"2021","journal-title":"Ther. Adv. Vaccines Immunother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/CVI.00249-07","article-title":"Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model","volume":"14","author":"Seino","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/ni.1963","article-title":"ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses","volume":"12","author":"Hayakawa","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/vbz.2017.2224","article-title":"Generation of a Lineage II Powassan Virus (Deer Tick Virus) cDNA Clone: Assessment of Flaviviral Genetic Determinants of Tick and Mosquito Vector Competence","volume":"18","author":"Kenney","year":"2018","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1093\/nar\/gkz581","article-title":"The role of ZAP and OAS3\/RNAseL pathways in the attenuation of an RNA virus with elevated frequencies of CpG and UpA dinucleotides","volume":"47","author":"Odon","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.1073\/pnas.1919269117","article-title":"Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody","volume":"117","author":"Esswein","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e00715-19","DOI":"10.1128\/JVI.00715-19","article-title":"Characterization of Novel Splice Variants of Zinc Finger Antiviral Protein (ZAP)","volume":"93","author":"Li","year":"2019","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11908-017-0566-9","article-title":"Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day","volume":"19","author":"Collins","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.coviro.2012.02.011","article-title":"Degrees of maturity: The complex structure and biology of flaviviruses","volume":"2","author":"Pierson","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Meier, K.C., Gardner, C.L., Khoretonenko, M.V., Klimstra, W.B., and Ryman, K.D. (2009). A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000614"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.virol.2009.01.038","article-title":"West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors","volume":"387","author":"Moudy","year":"2009","journal-title":"Virology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e01348-17","DOI":"10.1128\/JVI.01348-17","article-title":"Zika Virus Encoding Nonglycosylated Envelope Protein Is Attenuated and Defective in Neuroinvasion","volume":"91","author":"Annamalai","year":"2017","journal-title":"J. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e00046-18","DOI":"10.1128\/mBio.00046-18","article-title":"N-glycosylation of Viral E Protein Is the Determinant for Vector Midgut Invasion by Flaviviruses","volume":"9","author":"Wen","year":"2018","journal-title":"mBio"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12985-016-0590-7","article-title":"Flavivirus NS1: A multifaceted enigmatic viral protein","volume":"13","author":"Rastogi","year":"2016","journal-title":"Virol. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/viro.1996.0406","article-title":"Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: Effects on virus replication and mouse neurovirulence","volume":"222","author":"Muylaert","year":"1996","journal-title":"Virology"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Fros, J.J., Visser, I., Tang, B., Yan, K., Nakayama, E., Visser, T.M., Koenraadt, C.J.M., van Oers, M.M., Pijlman, G.P., and Suhrbier, A. (2021). The dinucleotide composition of the Zika virus genome is shaped by conflicting evolutionary pressures in mammalian hosts and mosquito vectors. PLoS Biol., 19.","DOI":"10.1371\/journal.pbio.3001201"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e01138-20","DOI":"10.1128\/mSphere.01138-20","article-title":"Association of Zinc Finger Antiviral Protein Binding to Viral Genomic RNA with Attenuation of Replication of Echovirus 7","volume":"6","author":"Goonawardane","year":"2021","journal-title":"mSphere"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e12735","DOI":"10.7554\/eLife.12735","article-title":"Elevation of CpG frequencies in influenza A genome attenuates pathogenicity but enhances host response to infection","volume":"5","author":"Gaunt","year":"2016","journal-title":"eLife"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e46767","DOI":"10.7554\/eLife.46767","article-title":"KHNYN is essential for the zinc finger antiviral protein (ZAP) to restrict HIV-1 containing clustered CpG dinucleotides","volume":"8","author":"Ficarelli","year":"2019","journal-title":"eLife"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Li, M.M., Lau, Z., Cheung, P., Aguilar, E.G., Schneider, W.M., Bozzacco, L., Molina, H., Buehler, E., Takaoka, A., and Rice, C.M. (2017). TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP). PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006145"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/3\/612\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:50:49Z","timestamp":1760122249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/3\/612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["vaccines11030612"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11030612","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]}}}